Aims/hypothesis: LARS2 has been previously identified as a potential type 2 diabetes susceptibility gene through the low-frequency H324Q (rs71645922) variant (minor allele frequency [MAF] 3.0%). However, this association did not achieve genome-wide levels of significance. The aim of this study was to establish the true contribution of this variant and common variants in LARS2 (MAF>5%) to type 2 diabetes risk. Methods: We combined genome-wide association data (n=10,128) from the DIAGRAM consortium with independent data derived from a tagging single nucleotide polymorphism (SNP) approach in Dutch individuals (n=999) and took forward two SNPs of interest to replication in up to 11,163 Dutch participants (rs17637703 and rs952621). In addition, because inspection of genome-wide association study data identified a cluster of low-frequency variants with evidence of type 2 diabetes association, we attempted replication of rs9825041 (a proxy for this group) and the previously identified H324Q variant in up to 35,715 participants of European descent. Results: No association between the common SNPs in LARS2 and type 2 diabetes was found. Our replication studies for the two low-frequency variants, rs9825041 and H324Q, failed to confirm an association with type 2 diabetes in Dutch, Scandinavian and UK samples (OR 1.03 [95% CI 0.95-1.12], p=0.45, n=31,962 and OR 0.99 [0.90-1.08], p=0.78, n=35,715 respectively). Conclusions/interpretation: In this study, the largest study examining the role of sequence variants in LARS2 in type 2 diabetes susceptibility, we found no evidence to support previous data indicating a role in type 2 diabetes susceptibility.

Additional Metadata
Keywords Genetics, LARS2, Mitochondria, SNP, Type 2 diabetes
Persistent URL dx.doi.org/10.1007/s00125-009-1557-7, hdl.handle.net/1765/25595
Citation
Reiling, E., Jafar-Mohammadi, B., van 't Riet, E., Weedon, M.N., van Vliet-Ostaptchouk, J.V., Hansen, T., … 't Hart, L.M.. (2010). Genetic association analysis of LARS2 with type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 53(1), 103–110. doi:10.1007/s00125-009-1557-7